Metformin, known for its efficacy in reducing hepatic glucose release and augmenting the body’s insulin sensitivity, has recently also been highlighted for its potential neuroprotective role in neurodegenerative disorders including PD. The gene discussed is INS; the disease is Parkinson disease.